CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares are moving higher Monday after the company presented preclinical data ...

CERo Therapeutics (CERO) announces the presentation of preclinical data demonstrating the capability of its lead compound CER-1236 to kill ...

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- ...

This year, TechCrunch Disrupt 2024 showcased the incredible talent and groundbreaking ideas of our 2024 Startup Battlefield ...

B.Riley Financial analyst Mayank Mamtani maintained a Hold rating on Cognition Therapeutics (CGTX – Research Report) today and set a ...

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's ...

Additions of Elyse Seltzer, M.D., as CMO and Robert Francomano as CCO Strengthen Company's Presence in the U.S. Seasoned Team to Drive Forward Pivotal Phase 3 Trial of Emactuzumab in Patients ...

Tokyo, Japan and London and Cardiff, UK, 5 November 2024 - Nxera Pharma ("Nxera”; TSE 4565) - formerly known as Sosei Group ...

Good afternoon and welcome to the Trevi Therapeutics3rd Quarter, 2024 earnings conference call. At this time, all participants will be in listen-only mode. (Operator Instruction) Please note this ...

Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced the appointment of Greg Weaver as Chief Financial Officer ...

Clinical-stage biotechnology company Tryptamine Therapeutics Ltd (ASX:TYP, OTC:TYPTF) has secured firm commitments to raise A$6 million to accelerate its clinical trial strategy for lead program ...

The Adrenaverse platform is a relatively new platform by Aquestive. This platform is essentially the 'secret-sauce' ...